Skip to content

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-002408-34-FI
Enrollment
Unknown
Registered
2011-06-28
Start date
2011-10-05
Completion date
Unknown
Last updated
2014-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10000058 Term: Abdominal crampy pains System Organ Class: 10017947 - Gastrointestinal disorders

Interventions

Trade Name: Buscopan Pharmaceutical Form: Solution for injection INN or Proposed INN: Hyoskiinibutyylibromidi CAS Number: 149-64-4 Other descriptive name: HYOSCINE BUTYLBROMIDE Pharmaceutical form of

Sponsors

Matti Ristikankare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 70 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Finland

Contacts

Public ContactLaakso Hospital

Matti Ristikankare

matti.ristikankare@kolumbus.fi+358503279448

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026